Skip to main content
Erschienen in: Journal of Neurology 5/2019

19.02.2019 | Original Communication

Blood pressure circadian rhythm alterations in alpha-synucleinopathies

verfasst von: Fabrizio Vallelonga, Cristina Di Stefano, Aristide Merola, Alberto Romagnolo, Gabriele Sobrero, Valeria Milazzo, Alessio Burrello, Jacopo Burrello, Maurizio Zibetti, Franco Veglio, Simona Maule

Erschienen in: Journal of Neurology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We sought to analyze the blood pressure (BP) circadian rhythm in Parkinson’s disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) and to evaluate the effect of vasoactive and dopaminergic medications on BP fluctuations during activities of daily living.

Methods

We analyzed data from patients with PD (n = 72), MSA (n = 18), and PAF (n = 17) evaluated with 24-h ambulatory BP monitoring (ABPM) at our Center between 1996 and 2015. Comparisons between groups were performed according to (a) clinical diagnosis and (b) pharmacological treatment. ABPM parameters included 24-h BP variability, BP load, nocturnal dipping, and awakening hypotension.

Results

The average BP was 121 ± 14/72 ± 8 mmHg during daytime and 133 ± 20/76 ± 13 mmHg during nighttime (p < 0.01), with BP load of 24 ± 22/15 ± 16% (daytime) vs. 61 ± 36/52 ± 36% (nighttime) (p < 0.01). In-office BP measurements were consistent with OH in 95 patients (89%) and SH in 63 (59%). ABPM demonstrated increased BP variability in 67 patients (63%), awakening hypotension in 63 (59%), “reverse dipping” in 85 (79.4%), “reduced dipping” in 13 (12.1%), and “normal dipping” in 9 (8.4%). No differences were observed between PD, MSA, and PAF, but a sub-analysis of PD patients revealed two distinct patterns of BP alterations. No significant differences were observed in relation to the use of vasoactive or dopaminergic medications.

Conclusion

Regardless of the neurological diagnosis and pharmacological treatment, patients with alpha-synucleinopathies showed a BP circadian rhythm characterized by increased BP variability, reverse dipping, increased BP load, and awakening hypotension.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mathias CJ (2003) Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 74(Suppl 3):iii31–i41PubMedPubMedCentral Mathias CJ (2003) Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 74(Suppl 3):iii31–i41PubMedPubMedCentral
2.
Zurück zum Zitat Milazzo V, Di Stefano C, Milan A, Ravera A, Sobrero G, Sabia L, Veglio F, Maule S (2015) Cardiovascular complications in patients with autonomic failure. Clin Auton Res 25:133–140CrossRefPubMed Milazzo V, Di Stefano C, Milan A, Ravera A, Sobrero G, Sabia L, Veglio F, Maule S (2015) Cardiovascular complications in patients with autonomic failure. Clin Auton Res 25:133–140CrossRefPubMed
3.
Zurück zum Zitat Spallone V, Maiello MR, Morganti R, Mandica S, Frajese G (2007) Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. J Hum Hypertens 21:381–386CrossRefPubMed Spallone V, Maiello MR, Morganti R, Mandica S, Frajese G (2007) Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. J Hum Hypertens 21:381–386CrossRefPubMed
4.
Zurück zum Zitat Milazzo V, Di Stefano C, Vallelonga F, Sobrero G, Zibetti M, Romagnolo A, Merola A, Milan A, Espay AJ, Lopiano L, Veglio F, Maule S (2018) Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Parkinsonism Relat Disord 56:82–87CrossRefPubMed Milazzo V, Di Stefano C, Vallelonga F, Sobrero G, Zibetti M, Romagnolo A, Merola A, Milan A, Espay AJ, Lopiano L, Veglio F, Maule S (2018) Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Parkinsonism Relat Disord 56:82–87CrossRefPubMed
5.
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRefPubMed
6.
Zurück zum Zitat Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMedPubMedCentral Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Singer W, Berini SE, Sandroni P, Fealey RD, Coon EA, Suarez MD, Benarroch EE, Low PA (2017) Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology 88:1129–1136CrossRefPubMedPubMedCentral Singer W, Berini SE, Sandroni P, Fealey RD, Coon EA, Suarez MD, Benarroch EE, Low PA (2017) Pure autonomic failure: predictors of conversion to clinical CNS involvement. Neurology 88:1129–1136CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27:639–653CrossRefPubMed Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27:639–653CrossRefPubMed
9.
Zurück zum Zitat Novak P (2011) Quantitative autonomic testing. J Vis Exp 19;(53):pii 2502 Novak P (2011) Quantitative autonomic testing. J Vis Exp 19;(53):pii 2502
10.
Zurück zum Zitat Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M (2006) EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 13:930–936CrossRefPubMed Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M (2006) EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 13:930–936CrossRefPubMed
11.
Zurück zum Zitat Fanciulli A, Jordan J, Biaggioni I et al (2018) Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. https://doi.org/10.1007/s10286-018-0529-8 CrossRefPubMedPubMedCentral Fanciulli A, Jordan J, Biaggioni I et al (2018) Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. https://​doi.​org/​10.​1007/​s10286-018-0529-8 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R (2012) The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 22:79–90CrossRefPubMed Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R (2012) The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 22:79–90CrossRefPubMed
13.
Zurück zum Zitat Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366CrossRefPubMed
14.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed Mancia G, Fagard R, Narkiewicz K et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRefPubMed
15.
Zurück zum Zitat James G, Witten D, Hastie T, Tibshirani R (2013) An Introduction to statistical learning: with applications in R. Springer texts in Statistics. Springer, New YorkCrossRef James G, Witten D, Hastie T, Tibshirani R (2013) An Introduction to statistical learning: with applications in R. Springer texts in Statistics. Springer, New YorkCrossRef
16.
Zurück zum Zitat Guo Q, Lu X, Gao Y, Zhang J, Yan B, Su D, Song A, Zhao X, Wang G (2017) Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients. Sci Rep 7:43965CrossRefPubMedPubMedCentral Guo Q, Lu X, Gao Y, Zhang J, Yan B, Su D, Song A, Zhao X, Wang G (2017) Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients. Sci Rep 7:43965CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Parikh KS, Rao Y, Ahmad T, Shen K, Felker GM, Rajagopal S (2017) Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis. Pulm Circ 7:486–493CrossRefPubMedPubMedCentral Parikh KS, Rao Y, Ahmad T, Shen K, Felker GM, Rajagopal S (2017) Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis. Pulm Circ 7:486–493CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653CrossRefPubMed
19.
Zurück zum Zitat Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffrè L, Rizzo M, Colosimo C, Caltagirone C, Poewe W, Wenning GK, Pontieri FE (2014) Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol 261:1291–1299CrossRefPubMed Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffrè L, Rizzo M, Colosimo C, Caltagirone C, Poewe W, Wenning GK, Pontieri FE (2014) Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol 261:1291–1299CrossRefPubMed
20.
Zurück zum Zitat Kang SJ, Ahn JY, Kim JS, Cho JW, Kim JY, Choi YY, Kim HT (2016) 24-h ambulatory blood pressure monitoring in SWEDDs patients with Parkinsonism. Can J Neurol Sci 43:390–397CrossRefPubMed Kang SJ, Ahn JY, Kim JS, Cho JW, Kim JY, Choi YY, Kim HT (2016) 24-h ambulatory blood pressure monitoring in SWEDDs patients with Parkinsonism. Can J Neurol Sci 43:390–397CrossRefPubMed
21.
Zurück zum Zitat Ejaz AA, Sekhon IS, Munjal S (2006) Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson’s disease. Eur J Intern Med 17:417–420CrossRefPubMed Ejaz AA, Sekhon IS, Munjal S (2006) Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson’s disease. Eur J Intern Med 17:417–420CrossRefPubMed
22.
Zurück zum Zitat Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16:1433–1441CrossRefPubMed Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16:1433–1441CrossRefPubMed
23.
Zurück zum Zitat Vichayanrat E, Low DA, Iodice V, Stuebner E, Hagen EM, Mathias CJ (2017) Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson’s disease and multiple system atrophy. Eur J Neurol 24:90–97CrossRefPubMed Vichayanrat E, Low DA, Iodice V, Stuebner E, Hagen EM, Mathias CJ (2017) Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson’s disease and multiple system atrophy. Eur J Neurol 24:90–97CrossRefPubMed
25.
Zurück zum Zitat Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE (2013) The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol 20:231–235CrossRefPubMed Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE (2013) The potential prognostic role of cardiovascular autonomic failure in alpha-synucleinopathies. Eur J Neurol 20:231–235CrossRefPubMed
26.
Zurück zum Zitat Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, Biaggioni I (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 61:701–706CrossRefPubMed Arnold AC, Okamoto LE, Gamboa A, Shibao C, Raj SR, Robertson D, Biaggioni I (2013) Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 61:701–706CrossRefPubMed
27.
Zurück zum Zitat Shibao C, Lipsitz LA, Biaggioni I (2013) ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens 15:147–153CrossRef Shibao C, Lipsitz LA, Biaggioni I (2013) ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens 15:147–153CrossRef
28.
Zurück zum Zitat Tulen JH,, van Steenis HG, Mechelse K (1991) Sleep patterns and blood pressure variability in patients with pure autonomic failure. Clin Auton Res 1:309–315CrossRefPubMed Tulen JH,, van Steenis HG, Mechelse K (1991) Sleep patterns and blood pressure variability in patients with pure autonomic failure. Clin Auton Res 1:309–315CrossRefPubMed
29.
Zurück zum Zitat Milazzo V, Maule S, Di Stefano C, Tosello F, Totaro S, Veglio F, Milan A (2015) Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension. Hypertension 66:1168–1175CrossRefPubMed Milazzo V, Maule S, Di Stefano C, Tosello F, Totaro S, Veglio F, Milan A (2015) Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension. Hypertension 66:1168–1175CrossRefPubMed
30.
Zurück zum Zitat Maule S, Milan A, Grosso T, Veglio F (2006) Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 19:1049–1054CrossRefPubMed Maule S, Milan A, Grosso T, Veglio F (2006) Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 19:1049–1054CrossRefPubMed
31.
Zurück zum Zitat Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, Battista F, Settimi L, Desamericq G, Dolbeau G, Faini A, Salvi P, Mannarino E, Parati G (2012) Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 60:369–377CrossRefPubMed Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, Battista F, Settimi L, Desamericq G, Dolbeau G, Faini A, Salvi P, Mannarino E, Parati G (2012) Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 60:369–377CrossRefPubMed
32.
Zurück zum Zitat Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, Biaggioni I, Robertson D (2009) Renal impairment of pure autonomic failure. Hypertension 54:1057–1061CrossRefPubMed Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, Biaggioni I, Robertson D (2009) Renal impairment of pure autonomic failure. Hypertension 54:1057–1061CrossRefPubMed
33.
Zurück zum Zitat Tha KK, Terae S, Yabe I, Miyamoto T, Soma H, Zaitsu Y, Fujima N, Kudo K, Sasaki H, Shirato H (2010) Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology 255:563–269CrossRefPubMed Tha KK, Terae S, Yabe I, Miyamoto T, Soma H, Zaitsu Y, Fujima N, Kudo K, Sasaki H, Shirato H (2010) Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology 255:563–269CrossRefPubMed
34.
Zurück zum Zitat Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H (2000) Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355:725–726CrossRefPubMed Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H (2000) Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355:725–726CrossRefPubMed
35.
Zurück zum Zitat Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T (2012) White matter hyperintensities in patients with multiple system atrophy. Parkinsonism Relat Disord 18:17–20CrossRefPubMed Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T (2012) White matter hyperintensities in patients with multiple system atrophy. Parkinsonism Relat Disord 18:17–20CrossRefPubMed
36.
Zurück zum Zitat Oh YS, Kim JS, Yang DW, Koo JS, Kim YI, Jung HO, Lee KS (2013) Nighttime blood pressure and white matter hyperintensities in patients with Parkinson disease. Chronobiol Int 30:811–817CrossRefPubMed Oh YS, Kim JS, Yang DW, Koo JS, Kim YI, Jung HO, Lee KS (2013) Nighttime blood pressure and white matter hyperintensities in patients with Parkinson disease. Chronobiol Int 30:811–817CrossRefPubMed
37.
Zurück zum Zitat Marti MJ, Tolosa E, Campdelacreu J (2003) Clinical overview of the synucleinopathies. Mov Disord 18(Suppl 6):S21–S27CrossRefPubMed Marti MJ, Tolosa E, Campdelacreu J (2003) Clinical overview of the synucleinopathies. Mov Disord 18(Suppl 6):S21–S27CrossRefPubMed
38.
Zurück zum Zitat Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349–358CrossRefPubMed Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349–358CrossRefPubMed
39.
Zurück zum Zitat Palma JA, Mano T (2018) Central or peripheral autonomic dysfunction in Parkinson disease: does it matter? Neurology 90:1045–1046CrossRefPubMed Palma JA, Mano T (2018) Central or peripheral autonomic dysfunction in Parkinson disease: does it matter? Neurology 90:1045–1046CrossRefPubMed
40.
Zurück zum Zitat Merola A, Espay AJ, Zibetti M, Romagnolo A, Rosso M, Maule S, Lopiano L (2017) Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: insights from the bedside. Mov Disord Clin Pract 4:141–144CrossRefPubMed Merola A, Espay AJ, Zibetti M, Romagnolo A, Rosso M, Maule S, Lopiano L (2017) Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: insights from the bedside. Mov Disord Clin Pract 4:141–144CrossRefPubMed
41.
Zurück zum Zitat Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D (2017) Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 81:287–297CrossRefPubMedPubMedCentral Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D (2017) Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 81:287–297CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94:192–196CrossRefPubMed Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94:192–196CrossRefPubMed
43.
Zurück zum Zitat Di Stefano C, Maule S (2017) Treatment of supine hypertension in autonomic failure: a case series. Clin Auton Res 28:245–246CrossRefPubMed Di Stefano C, Maule S (2017) Treatment of supine hypertension in autonomic failure: a case series. Clin Auton Res 28:245–246CrossRefPubMed
44.
Zurück zum Zitat Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264:1567:1582CrossRefPubMedPubMedCentral Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, Karabin B, Kuritzky L, Lew M, Low P, Mehdirad A, Raj SR, Vernino S, Kaufmann H (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264:1567:1582CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, Biaggioni I (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10:35–42PubMed Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, Biaggioni I (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10:35–42PubMed
46.
Zurück zum Zitat Calne DB, Teychenne PF (1977) L-DOPA effect on blood pressure in man. Prog Brain Res 47:331–336CrossRefPubMed Calne DB, Teychenne PF (1977) L-DOPA effect on blood pressure in man. Prog Brain Res 47:331–336CrossRefPubMed
47.
Zurück zum Zitat Noack C, Schroeder C, Heusser K, Lipp A (2014) Cardiovascular effects of levodopa in Parkinson’s disease. Parkinsonism Relat Disord 20:815–818CrossRefPubMed Noack C, Schroeder C, Heusser K, Lipp A (2014) Cardiovascular effects of levodopa in Parkinson’s disease. Parkinsonism Relat Disord 20:815–818CrossRefPubMed
48.
Zurück zum Zitat Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976CrossRefPubMed Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140:1959–1976CrossRefPubMed
49.
Zurück zum Zitat Iodice V, Low DA, Vichayanrat E, Mathias CJ (2011) Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci 310:133–138CrossRefPubMed Iodice V, Low DA, Vichayanrat E, Mathias CJ (2011) Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci 310:133–138CrossRefPubMed
50.
Zurück zum Zitat Norcliffe-Kaufmann L, Kaufmann H (2014) Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res 24:189–192CrossRefPubMed Norcliffe-Kaufmann L, Kaufmann H (2014) Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res 24:189–192CrossRefPubMed
51.
Zurück zum Zitat Merola A, Romagnolo A, Rosso M, Lopez-Castellanos JR, Wissel BD, Larkin S, Bernardini A, Zibetti M, Maule S, Lopiano L, Espay AJ (2016) Orthostatic hypotension in Parkinson’s disease: does it matter if asymptomatic? Parkinsonism Relat Disord 33:65–71CrossRefPubMed Merola A, Romagnolo A, Rosso M, Lopez-Castellanos JR, Wissel BD, Larkin S, Bernardini A, Zibetti M, Maule S, Lopiano L, Espay AJ (2016) Orthostatic hypotension in Parkinson’s disease: does it matter if asymptomatic? Parkinsonism Relat Disord 33:65–71CrossRefPubMed
52.
Zurück zum Zitat Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, Lopiano L, Espay AJ (2018) Autonomic dysfunction in Parkinson’s disease: a prospective cohort study. Mov Disord 33:391–397CrossRefPubMed Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, Lopiano L, Espay AJ (2018) Autonomic dysfunction in Parkinson’s disease: a prospective cohort study. Mov Disord 33:391–397CrossRefPubMed
53.
Zurück zum Zitat de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535CrossRefPubMed de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535CrossRefPubMed
54.
Zurück zum Zitat Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49:1284–1288CrossRefPubMed Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49:1284–1288CrossRefPubMed
Metadaten
Titel
Blood pressure circadian rhythm alterations in alpha-synucleinopathies
verfasst von
Fabrizio Vallelonga
Cristina Di Stefano
Aristide Merola
Alberto Romagnolo
Gabriele Sobrero
Valeria Milazzo
Alessio Burrello
Jacopo Burrello
Maurizio Zibetti
Franco Veglio
Simona Maule
Publikationsdatum
19.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 5/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09244-w

Weitere Artikel der Ausgabe 5/2019

Journal of Neurology 5/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.